X
IONS icon

Xponance’s Ionis Pharmaceuticals IONS Stock Holding History

Xponance’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Buy
26,687
+303
+1% +$22.8K 0.01% 572
2026
Q1 		$1.98M Buy
26,384
+3,443
+15% +$272K 0.01% 574
2025
Q4 		$1.81M Buy
22,941
+1,491
+7% +$112K 0.01% 561
2025
Q3 		$1.4M Sell
21,450
-1,304
-6% -$63.7K 0.01% 627
2025
Q2 		$899K Buy
22,754
+2,435
+12% +$79.7K 0.01% 728
2025
Q1 		$613K Buy
20,319
+980
+5% +$32.1K 0.01% 871
2024
Q4 		$676K Buy
19,339
+318
+2% +$11.9K 0.01% 855
2024
Q3 		$762K Buy
19,021
+906
+5% +$42.2K 0.01% 797
2024
Q2 		$863K Buy
18,115
+1,906
+12% +$78.2K 0.01% 722
2024
Q1 		$703K Sell
16,209
-484
-3% -$23.1K 0.01% 835
2023
Q4 		$844K Sell
16,693
-1,143
-6% -$54.7K 0.01% 733
2023
Q3 		$809K Sell
17,836
-430
-2% -$17.7K 0.01% 713
2023
Q2 		$749K Buy
18,266
+339
+2% +$13K 0.01% 754
2023
Q1 		$641K Buy
17,927
+217
+1% +$8.15K 0.01% 827
2022
Q4 		$669K Buy
17,710
+2,170
+14% +$91.3K 0.01% 789
2022
Q3 		$687K Buy
15,540
+122
+0.8% +$5.14K 0.01% 706
2022
Q2 		$571K Buy
15,418
+520
+3% +$19.6K 0.01% 808
2022
Q1 		$552K Buy
14,898
+8
+0.1% +$262 0.01% 860
2021
Q4 		$453K Buy
14,890
+318
+2% +$10K 0.01% 938
2021
Q3 		$489K Sell
14,572
-654
-4% -$24.6K 0.01% 899
2021
Q2 		$607K Buy
15,226
+8,423
+124% +$330K 0.01% 821
2021
Q1 		$306K Buy
6,803
+23
+0.3% +$1.28K 0.01% 955
2020
Q4 		$383K Buy
6,780
+209
+3% +$10.4K 0.01% 866
2020
Q3 		$312K Sell
6,571
-215
-3% -$11.9K 0.01% 842
2020
Q2 		$400K Buy
+6,786
New +$377K 0.01% 707

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Xponance's IONS Position: Q2 2026 in Review

Xponance increased its Ionis Pharmaceuticals (IONS) stake by 1.1% in Q2 2026, buying an estimated $22.8K and bringing the position to 26,687 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #572.

Xponance first reported a position in IONS in Q2 2020 and has held it in 25 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Xponance held 26,687 shares of Ionis Pharmaceuticals worth $2.12M as of Q2 2026.
  • Xponance bought 303 Ionis Pharmaceuticals shares in Q2 2026, an estimated $22.8K.
  • Ionis Pharmaceuticals made up 0.01% of Xponance's portfolio in Q2 2026, its #572 holding.
  • Xponance first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.